- Home
- Publications
- Publication Search
- Publication Details
Title
Parkinson disease
Authors
Keywords
-
Journal
Nature Reviews Disease Primers
Volume 3, Issue -, Pages 17013
Publisher
Springer Nature
Online
2017-03-23
DOI
10.1038/nrdp.2017.13
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical tests of neurotrophic factors for human neurodegenerative diseases, part 2: Where do we stand and where must we go next?
- (2017) Raymond T. Bartus et al. NEUROBIOLOGY OF DISEASE
- Clinical tests of neurotrophic factors for human neurodegenerative diseases, part 1: Where have we been and what have we learned?
- (2017) Raymond T. Bartus et al. NEUROBIOLOGY OF DISEASE
- Assessment of Safety and Efficacy of Safinamide as a Levodopa Adjunct in Patients With Parkinson Disease and Motor Fluctuations
- (2017) Anthony H. V. Schapira et al. JAMA Neurology
- Ambroxol effects in glucocerebrosidase and α-synuclein transgenic mice
- (2016) Anna Migdalska-Richards et al. ANNALS OF NEUROLOGY
- Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's
- (2016) Ganqiang Liu et al. ANNALS OF NEUROLOGY
- Survival and dementia inGBA-associated Parkinson's disease: The mutation matters
- (2016) Roberto Cilia et al. ANNALS OF NEUROLOGY
- Ade novocompound targeting α-synuclein improves deficits in models of Parkinson’s disease
- (2016) Wolfgang Wrasidlo et al. BRAIN
- Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease
- (2016) Timothy R. Sampson et al. CELL
- Functional Impairment in Miro Degradation and Mitophagy Is a Shared Feature in Familial and Sporadic Parkinson’s Disease
- (2016) Chung-Han Hsieh et al. Cell Stem Cell
- LRRK2 modulates microglial activity through regulation of chemokine (C–X3–C) receptor 1 –mediated signalling pathways
- (2016) Bo Ma et al. HUMAN MOLECULAR GENETICS
- Mitochondrial dysfunction in Parkinson's disease
- (2016) Anindita Bose et al. JOURNAL OF NEUROCHEMISTRY
- Sorting out release, uptake and processing of alpha-synuclein during prion-like spread of pathology
- (2016) Trevor Tyson et al. JOURNAL OF NEUROCHEMISTRY
- The Cerebral Network of Parkinson's Tremor: An Effective Connectivity fMRI Study
- (2016) Michiel F. Dirkx et al. JOURNAL OF NEUROSCIENCE
- G2019S-LRRK2 Expression Augments -Synuclein Sequestration into Inclusions in Neurons
- (2016) L. A. Volpicelli-Daley et al. JOURNAL OF NEUROSCIENCE
- New ISSCR guidelines: clinical translation of stem cell research
- (2016) Jonathan Kimmelman et al. LANCET
- Idiopathic rapid eye movement sleep behaviour disorder: diagnosis, management, and the need for neuroprotective interventions
- (2016) Alex Iranzo et al. LANCET NEUROLOGY
- Challenges of modifying disease progression in prediagnostic Parkinson's disease
- (2016) David Salat et al. LANCET NEUROLOGY
- Assessment of α-synuclein in submandibular glands of patients with idiopathic rapid-eye-movement sleep behaviour disorder: a case-control study
- (2016) Dolores Vilas et al. LANCET NEUROLOGY
- Opicapone as an adjunct to levodopa in patients with Parkinson's disease and end-of-dose motor fluctuations: a randomised, double-blind, controlled trial
- (2016) Joaquim J Ferreira et al. LANCET NEUROLOGY
- The epidemiology of Parkinson's disease: risk factors and prevention
- (2016) Alberto Ascherio et al. LANCET NEUROLOGY
- Genetics of Parkinson's disease
- (2016) Christina M. Lill MOLECULAR AND CELLULAR PROBES
- Innovations in deep brain stimulation methodology
- (2016) Andrea A. Kühn et al. MOVEMENT DISORDERS
- A review of disease progression models of Parkinson's disease and applications in clinical trials
- (2016) Charles S. Venuto et al. MOVEMENT DISORDERS
- Prodromal Parkinson's disease as defined per MDS research criteria in the general elderly community
- (2016) Philipp Mahlknecht et al. MOVEMENT DISORDERS
- Launching the movement disorders society genetic mutation database (MDSGene)
- (2016) Christina M. Lill et al. MOVEMENT DISORDERS
- Effect of levodopa-carbidopa intestinal gel on dyskinesia in advanced Parkinson's disease patients
- (2016) Angelo Antonini et al. MOVEMENT DISORDERS
- First-in-human assessment of PRX002, an anti-α-synuclein monoclonal antibody, in healthy volunteers
- (2016) Dale B. Schenk et al. MOVEMENT DISORDERS
- Technology in Parkinson's disease: Challenges and opportunities
- (2016) Alberto J. Espay et al. MOVEMENT DISORDERS
- Sublingual apomorphine (APL-130277) for the acute conversion of OFF to ON in Parkinson's disease
- (2016) Robert A. Hauser et al. MOVEMENT DISORDERS
- Nomenclature of genetic movement disorders: Recommendations of the international Parkinson and movement disorder society task force
- (2016) Connie Marras et al. MOVEMENT DISORDERS
- Parkinson-associated risk variant in distal enhancer of α-synuclein modulates target gene expression
- (2016) Frank Soldner et al. NATURE
- Identification of TMEM230 mutations in familial Parkinson's disease
- (2016) Han-Xiang Deng et al. NATURE GENETICS
- The Incidence of Parkinson's Disease: A Systematic Review and Meta-Analysis
- (2016) Lauren Hirsch et al. NEUROEPIDEMIOLOGY
- The diagnostic discrimination of cutaneous α-synuclein deposition in Parkinson disease
- (2016) Christopher H. Gibbons et al. NEUROLOGY
- Accuracy of clinical diagnosis of Parkinson disease
- (2016) Giovanni Rizzo et al. NEUROLOGY
- Diagnostic potential of automated subcortical volume segmentation in atypical parkinsonism
- (2016) Christoph Scherfler et al. NEUROLOGY
- GPi vs STN deep brain stimulation for Parkinson disease
- (2016) Vincent J.J. Odekerken et al. NEUROLOGY
- Levodopa therapy for Parkinson disease: Table
- (2016) Peter A. LeWitt et al. NEUROLOGY
- Cognitive decline and quality of life in incident Parkinson's disease: The role of attention
- (2016) Rachael A. Lawson et al. PARKINSONISM & RELATED DISORDERS
- Biomarkers in Parkinson's disease: Advances and strategies
- (2016) Marion Delenclos et al. PARKINSONISM & RELATED DISORDERS
- Pathological -synuclein transmission initiated by binding lymphocyte-activation gene 3
- (2016) X. Mao et al. SCIENCE
- How neuroinflammation contributes to neurodegeneration
- (2016) R. M. Ransohoff SCIENCE
- Magnetic resonance imaging as a potential biomarker for Parkinson's disease
- (2016) Paul Tuite Translational Research
- Are Stem Cell-Based Therapies for Parkinson’s Disease Ready for the Clinic in 2016?
- (2016) Roger A. Barker et al. Journal of Parkinsons Disease
- ER Stress and Autophagic Perturbations Lead to Elevated Extracellular α-Synuclein in GBA-N370S Parkinson's iPSC-Derived Dopamine Neurons
- (2016) Hugo J.R. Fernandes et al. Stem Cell Reports
- Where and what is the PPN and what is its role in locomotion?
- (2015) Francois Windels et al. BRAIN
- Catechol-O-Methyltransferase Inhibitors in Parkinson’s Disease
- (2015) Thomas Müller DRUGS
- VPS35 in Dopamine Neurons Is Required for Endosome-to-Golgi Retrieval of Lamp2a, a Receptor of Chaperone-Mediated Autophagy That Is Critical for -Synuclein Degradation and Prevention of Pathogenesis of Parkinson's Disease
- (2015) F.-L. Tang et al. JOURNAL OF NEUROSCIENCE
- Parkinson's disease
- (2015) Lorraine V Kalia et al. LANCET
- Diagnosis of Parkinson's disease on the basis of clinical and genetic classification: a population-based modelling study
- (2015) Mike A Nalls et al. LANCET NEUROLOGY
- New clinical trials for nonmotor manifestations of Parkinson's disease
- (2015) Anette Schrag et al. MOVEMENT DISORDERS
- Basic science breaks through: New therapeutic advances in Parkinson's disease
- (2015) Patrik Brundin et al. MOVEMENT DISORDERS
- Development of Passive Immunotherapies for Synucleinopathies
- (2015) Ann-Louise Bergström et al. MOVEMENT DISORDERS
- Plasma apolipoprotein A1 associates with age at onset and motor severity in early Parkinson's disease patients
- (2015) Christine R. Swanson et al. MOVEMENT DISORDERS
- Dorsolateral nigral hyperintensity on 3.0T susceptibility-weighted imaging in neurodegenerative Parkinsonism
- (2015) Eva Reiter et al. MOVEMENT DISORDERS
- MDS clinical diagnostic criteria for Parkinson's disease
- (2015) Ronald B. Postuma et al. MOVEMENT DISORDERS
- MDS research criteria for prodromal Parkinson's disease
- (2015) Daniela Berg et al. MOVEMENT DISORDERS
- Nonpharmacological treatments for patients with Parkinson's disease
- (2015) Bastiaan R. Bloem et al. MOVEMENT DISORDERS
- Proteostasis and aging
- (2015) Susmita Kaushik et al. NATURE MEDICINE
- Cell-based therapies for Parkinson disease—past insights and future potential
- (2015) Roger A. Barker et al. Nature Reviews Neurology
- Progressive nigrostriatal terminal dysfunction and degeneration in the engrailed1 heterozygous mouse model of Parkinson's disease
- (2015) Ulrika Nordström et al. NEUROBIOLOGY OF DISEASE
- Spreading of α-synuclein in the face of axonal transport deficits in Parkinson's disease: A speculative synthesis
- (2015) Jennifer T. Lamberts et al. NEUROBIOLOGY OF DISEASE
- Parkinson disease and incidental Lewy body disease
- (2015) Diego Iacono et al. NEUROLOGY
- Enteric nervous system α-synuclein immunoreactivity in idiopathic REM sleep behavior disorder
- (2015) Fabienne S. Sprenger et al. NEUROLOGY
- Olfactory dysfunction predicts early transition to a Lewy body disease in idiopathic RBD
- (2015) P. Mahlknecht et al. NEUROLOGY
- Parkinson’s Disease Genes VPS35 and EIF4G1 Interact Genetically and Converge on α-Synuclein
- (2015) Nripesh Dhungel et al. NEURON
- The Roles of PINK1, Parkin, and Mitochondrial Fidelity in Parkinson’s Disease
- (2015) Alicia M. Pickrell et al. NEURON
- M1 and M2 immune activation in Parkinson’s Disease: Foe and ally?
- (2015) M.S. Moehle et al. NEUROSCIENCE
- Predictors of the psychosocial impact of being a carer of people living with Parkinson's disease: A systematic review
- (2015) Kate Greenwell et al. PARKINSONISM & RELATED DISORDERS
- Immunotherapy in Parkinson’s Disease: Micromanaging Alpha-Synuclein Aggregation
- (2015) Sonia George et al. Journal of Parkinsons Disease
- The Concept of Prodromal Parkinson’s Disease
- (2015) Philipp Mahlknecht et al. Journal of Parkinsons Disease
- Role of Different Alpha-Synuclein Strains in Synucleinopathies, Similarities with other Neurodegenerative Diseases
- (2015) Ronald Melki Journal of Parkinsons Disease
- Motor and Cognitive Advantages Persist 12 Months After Exenatide Exposure in Parkinson’s Disease
- (2015) Iciar Aviles-Olmos et al. Journal of Parkinsons Disease
- The Synaptic Function of α-Synuclein
- (2015) Jacqueline Burré Journal of Parkinsons Disease
- Next-generation active immunization approach for synucleinopathies: implications for Parkinson’s disease clinical trials
- (2014) Markus Mandler et al. ACTA NEUROPATHOLOGICA
- Cutaneous neuropathy in Parkinson’s disease: a window into brain pathology
- (2014) Kathrin Doppler et al. ACTA NEUROPATHOLOGICA
- Mutual exacerbation of peroxisome proliferator-activated receptor γ coactivator 1α deregulation and α-synuclein oligomerization
- (2014) Judith Eschbach et al. ANNALS OF NEUROLOGY
- Physical activity and risk of Parkinson’s disease in the Swedish National March Cohort
- (2014) Fei Yang et al. BRAIN
- Membrane recruitment of endogenous LRRK2 precedes its potent regulation of autophagy
- (2014) J. Schapansky et al. HUMAN MOLECULAR GENETICS
- Pharmacological Treatment of Parkinson Disease
- (2014) Barbara S. Connolly et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial
- (2014) Stéphane Palfi et al. LANCET
- Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson's disease (PD MED): a large, open-label, pragmatic randomised trial
- (2014) PD MED Collaborative Group LANCET
- Imaging insights into basal ganglia function, Parkinson's disease, and dystonia
- (2014) A Jon Stoessl et al. LANCET
- Novel formulations and modes of delivery of levodopa
- (2014) Werner Poewe et al. MOVEMENT DISORDERS
- Mortality in Parkinson's disease: A 38-year follow-up study
- (2014) Bernadette Pinter et al. MOVEMENT DISORDERS
- The Onset of Nonmotor Symptoms in Parkinson's disease (The ONSET PDStudy)
- (2014) Claustre Pont-Sunyer et al. MOVEMENT DISORDERS
- Stage-dependent nigral neuronal loss in incidental Lewy body and Parkinson's disease
- (2014) Anke A. Dijkstra et al. MOVEMENT DISORDERS
- The prevalence of Parkinson's disease: A systematic review and meta-analysis
- (2014) Tamara Pringsheim et al. MOVEMENT DISORDERS
- Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease
- (2014) Mike A Nalls et al. NATURE GENETICS
- Neuroimaging in Parkinson disease: from research setting to clinical practice
- (2014) Marios Politis Nature Reviews Neurology
- Imaging prodromal Parkinson disease: The Parkinson Associated Risk Syndrome Study
- (2014) D. Jennings et al. NEUROLOGY
- Unbiased Approaches to Biomarker Discovery in Neurodegenerative Diseases
- (2014) Alice S. Chen-Plotkin NEURON
- MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration
- (2014) Carolina Cebrián et al. Nature Communications
- Inosine to Increase Serum and Cerebrospinal Fluid Urate in Parkinson Disease
- (2014) Michael A. Schwarzschild et al. JAMA Neurology
- Presynaptic Mechanisms of l-DOPA-Induced Dyskinesia: The Findings, the Debate, and the Therapeutic Implications
- (2014) M. Angela Cenci Frontiers in Neurology
- Disease duration and the integrity of the nigrostriatal system in Parkinson’s disease
- (2013) Jeffrey H. Kordower et al. BRAIN
- α-Synuclein: The Long Distance Runner
- (2013) Sonia George et al. BRAIN PATHOLOGY
- Emerging drugs for autonomic dysfunction in Parkinson's disease
- (2013) Santiago Perez-Lloret et al. EXPERT OPINION ON EMERGING DRUGS
- Lewy Body-like α-Synuclein Aggregates Resist Degradation and Impair Macroautophagy
- (2013) Selcuk A. Tanik et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Nonmotor Symptoms in Nursing Home Residents with Parkinson's Disease: Prevalence and Effect on Quality of Life
- (2013) Nico J. Weerkamp et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial
- (2013) Jeffrey Cummings et al. LANCET
- Subthalamic neurostimulation for Parkinson's disease with early fluctuations: balancing the risks and benefits
- (2013) Günther Deuschl et al. LANCET NEUROLOGY
- Trophic Factor Gene Therapy for Parkinson's Disease
- (2013) Jeffrey H. Kordower et al. MOVEMENT DISORDERS
- Phase II safety, tolerability, and dose selection study of isradipine as a potential disease-modifying intervention in early Parkinson's disease (STEADY-PD)
- (2013) MOVEMENT DISORDERS
- Nonmotor fluctuations in Parkinson disease: Severity and correlation with motor complications
- (2013) A. Storch et al. NEUROLOGY
- Randomized trial of deep brain stimulation for Parkinson disease: Thirty-six-month outcomes; Turning tables: Should GPi become the preferred DBS target for parkinson disease?
- (2013) E. B. Montgomery et al. NEUROLOGY
- Review: The future of cell therapies and brain repair: Parkinson's disease leads the way
- (2013) G. H. Petit et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Changes in substantia nigra and locus coeruleus in patients with early-stage Parkinson's disease using neuromelanin-sensitive MR imaging
- (2013) Chigumi Ohtsuka et al. NEUROSCIENCE LETTERS
- Treatment of Cognitive, Psychiatric, and Affective Disorders Associated with Parkinson’s Disease
- (2013) Barbara Connolly et al. Neurotherapeutics
- Augmenting CNS glucocerebrosidase activity as a therapeutic strategy for parkinsonism and other Gaucher-related synucleinopathies
- (2013) S. Pablo Sardi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The energy cost of action potential propagation in dopamine neurons: clues to susceptibility in Parkinson's disease
- (2013) Eleftheria K. Pissadaki et al. Frontiers in Computational Neuroscience
- Incidence and Pathology of Synucleinopathies and Tauopathies Related to Parkinsonism
- (2013) Rodolfo Savica et al. JAMA Neurology
- Long-term Clinical Outcome of Fetal Cell Transplantation for Parkinson Disease
- (2013) Zinovia Kefalopoulou et al. JAMA Neurology
- Lysosomal dysfunction in Parkinson disease
- (2012) Benjamin Dehay et al. Autophagy
- Therapies in Parkinsonʼs disease
- (2012) Joseph Jankovic et al. CURRENT OPINION IN NEUROLOGY
- Long-Term Evaluation of a Phase 1 Study of AADC Gene Therapy for Parkinson's Disease
- (2012) Gabriele Mittermeyer et al. HUMAN GENE THERAPY
- Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010
- (2012) Christopher J L Murray et al. LANCET
- Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010
- (2012) Theo Vos et al. LANCET
- Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study): a randomised controlled trial
- (2012) Vincent JJ Odekerken et al. LANCET NEUROLOGY
- Inflammation and α-Synuclein’s Prion-like Behavior in Parkinson's Disease—Is There a Link?
- (2012) Carla M. Lema Tomé et al. MOLECULAR NEUROBIOLOGY
- Alpha-synuclein and Protein Degradation Systems: a Reciprocal Relationship
- (2012) Maria Xilouri et al. MOLECULAR NEUROBIOLOGY
- Latrepirdine stimulates autophagy and reduces accumulation of α-synuclein in cells and in mouse brain
- (2012) J W Steele et al. MOLECULAR PSYCHIATRY
- Effectiveness of multidisciplinary care for Parkinson's disease: A randomized, controlled trial
- (2012) Marjolein A. van der Marck et al. MOVEMENT DISORDERS
- Parkinson's disease among American Indians and Alaska natives: A nationwide prevalence study
- (2012) Paul H. Gordon et al. MOVEMENT DISORDERS
- Novel nondopaminergic targets for motor features of Parkinson's disease: Review of recent trials
- (2012) Lorraine V. Kalia et al. MOVEMENT DISORDERS
- Living on the edge with too many mouths to feed: Why dopamine neurons die
- (2012) J. Paul Bolam et al. MOVEMENT DISORDERS
- Toward a redefinition of Parkinson's disease
- (2012) Matthew B. Stern et al. MOVEMENT DISORDERS
- Therapeutic Deep Brain Stimulation in Parkinsonian Rats Directly Influences Motor Cortex
- (2012) Qian Li et al. NEURON
- Neuropathology underlying clinical variability in patients with synucleinopathies
- (2011) Glenda M. Halliday et al. ACTA NEUROPATHOLOGICA
- A Mutation in VPS35, Encoding a Subunit of the Retromer Complex, Causes Late-Onset Parkinson Disease
- (2011) Alexander Zimprich et al. AMERICAN JOURNAL OF HUMAN GENETICS
- VPS35 Mutations in Parkinson Disease
- (2011) Carles Vilariño-Güell et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Gaucher Disease Glucocerebrosidase and α-Synuclein Form a Bidirectional Pathogenic Loop in Synucleinopathies
- (2011) Joseph R. Mazzulli et al. CELL
- Monoamine Oxidase B Inhibitors for the Treatment of Parkinsonʼs Disease
- (2011) Anthony H.V. Schapira CNS DRUGS
- Impulse control disorders in Parkinsonʼs disease
- (2011) Valerie Voon et al. CURRENT OPINION IN NEUROLOGY
- Pathological roles of α-synuclein in neurological disorders
- (2011) Kostas Vekrellis et al. LANCET NEUROLOGY
- AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial
- (2011) Peter A LeWitt et al. LANCET NEUROLOGY
- Nonmotor versus motor symptoms: How much do they matter to health status in Parkinson's disease?
- (2011) Claire Hinnell et al. MOVEMENT DISORDERS
- The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease
- (2011) Klaus Seppi et al. MOVEMENT DISORDERS
- Parkinson's disease: The quintessential neuropsychiatric disorder
- (2011) Daniel Weintraub et al. MOVEMENT DISORDERS
- The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease
- (2011) Susan H. Fox et al. MOVEMENT DISORDERS
- Does vigorous exercise have a neuroprotective effect in Parkinson disease?
- (2011) J. E. Ahlskog NEUROLOGY
- The role of calcium and mitochondrial oxidant stress in the loss of substantia nigra pars compacta dopaminergic neurons in Parkinson's disease
- (2011) D.J. Surmeier et al. NEUROSCIENCE
- Predictors of Parkin Mutations in Early-Onset Parkinson Disease
- (2010) Karen S. Marder et al. ARCHIVES OF NEUROLOGY
- Frequency of Known Mutations in Early-Onset Parkinson Disease
- (2010) Roy N. Alcalay et al. ARCHIVES OF NEUROLOGY
- Chaperone-Mediated Autophagy Markers in Parkinson Disease Brains
- (2010) Lydia Alvarez-Erviti et al. ARCHIVES OF NEUROLOGY
- Deep Brain Stimulation for Parkinson Disease
- (2010) Jeff M. Bronstein et al. ARCHIVES OF NEUROLOGY
- α-Synuclein impairs macroautophagy: implications for Parkinson’s disease
- (2010) Ashley R. Winslow et al. JOURNAL OF CELL BIOLOGY
- Pathogenic Lysosomal Depletion in Parkinson's Disease
- (2010) B. Dehay et al. JOURNAL OF NEUROSCIENCE
- Are synucleinopathies prion-like disorders?
- (2010) Elodie Angot et al. LANCET NEUROLOGY
- Role of serotonin neurons in the induction of levodopa- and graft-induced dyskinesias in Parkinson's disease
- (2010) Manolo Carta et al. MOVEMENT DISORDERS
- Dopamine turnover increases in asymptomatic LRRK2 mutations carriers
- (2010) Vesna Sossi et al. MOVEMENT DISORDERS
- Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1
- (2010) Jaime N. Guzman et al. NATURE
- Prion-like transmission of protein aggregates in neurodegenerative diseases
- (2010) Patrik Brundin et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Significance of MRI in Diagnosis and Differential Diagnosis of Parkinson’s Disease
- (2010) Philipp Mahlknecht et al. Neurodegenerative Diseases
- Physical activities and future risk of Parkinson disease
- (2010) Q. Xu et al. NEUROLOGY
- PGC-1 , A Potential Therapeutic Target for Early Intervention in Parkinson's Disease
- (2010) B. Zheng et al. Science Translational Medicine
- The progression of pathology in Parkinson's disease
- (2009) Glenda Margaret Halliday et al. Annals of the New York Academy of Sciences
- Overview of the Extranigral Aspects of Parkinson Disease
- (2009) Shen-Yang Lim et al. ARCHIVES OF NEUROLOGY
- Priming for L-DOPA-induced abnormal involuntary movements increases the severity of amphetamine-induced dyskinesia in grafted rats
- (2009) E.L. Lane et al. EXPERIMENTAL NEUROLOGY
- Socioeconomic variations in the prevalence and incidence of Parkinson's disease: a population-based analysis
- (2009) L. M Lix et al. JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH
- Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment
- (2009) K Ray Chaudhuri et al. LANCET NEUROLOGY
- Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria
- (2009) Dennis W Dickson et al. LANCET NEUROLOGY
- Neuroinflammation in Parkinson's disease: a target for neuroprotection?
- (2009) Etienne C Hirsch et al. LANCET NEUROLOGY
- Alterations in lysosomal and proteasomal markers in Parkinson's disease: Relationship to alpha-synuclein inclusions
- (2009) Yaping Chu et al. NEUROBIOLOGY OF DISEASE
- Interplay between Cytosolic Dopamine, Calcium, and α-Synuclein Causes Selective Death of Substantia Nigra Neurons
- (2009) Eugene V. Mosharov et al. NEURON
- Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
- (2009) E. Sidransky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Abberant α-Synuclein Confers Toxicity to Neurons in Part through Inhibition of Chaperone-Mediated Autophagy
- (2009) Maria Xilouri et al. PLoS One
- Optical Deconstruction of Parkinsonian Neural Circuitry
- (2009) V. Gradinaru et al. SCIENCE
- Gene Therapy for Dopamine Replacement in Parkinsons Disease
- (2009) A. Bjorklund et al. Science Translational Medicine
- Mitochondrial Import and Accumulation of α-Synuclein Impair Complex I in Human Dopaminergic Neuronal Cultures and Parkinson Disease Brain
- (2008) Latha Devi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Controlling the mass action of α-synuclein in Parkinson’s disease
- (2008) Changyoun Kim et al. JOURNAL OF NEUROCHEMISTRY
- Neuroinflammation and Oxidation/Nitration of -Synuclein Linked to Dopaminergic Neurodegeneration
- (2008) H.-M. Gao et al. JOURNAL OF NEUROSCIENCE
- High-Frequency Stimulation of the Subthalamic Nucleus Suppresses Oscillatory Activity in Patients with Parkinson's Disease in Parallel with Improvement in Motor Performance
- (2008) A. A. Kuhn et al. JOURNAL OF NEUROSCIENCE
- The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years
- (2008) Mariese A. Hely et al. MOVEMENT DISORDERS
- Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results
- (2008) Christopher G. Goetz et al. MOVEMENT DISORDERS
- Physical therapy in Parkinson's disease: Evolution and future challenges
- (2008) Samyra H.J. Keus et al. MOVEMENT DISORDERS
- Research in motion: the enigma of Parkinson's disease pathology spread
- (2008) Patrik Brundin et al. NATURE REVIEWS NEUROSCIENCE
- Cell-produced α-synuclein oligomers are targeted to, and impair, the 26S proteasome
- (2008) Evangelia Emmanouilidou et al. NEUROBIOLOGY OF AGING
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now